A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Clinical trial NCT05813912 · COMPLETED
Trial details
- NCT number
- NCT05813912
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-22
- Primary completion
- 2025-04-14
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.